Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/169
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chimalizeni, Yamikani | en |
dc.contributor.author | Tickell, David | en |
dc.contributor.author | Connell, Tom | en |
dc.date.accessioned | 2013-01-14T00:09:10Z | en |
dc.date.available | 2013-01-14T00:09:10Z | en |
dc.date.issued | 2010 | en |
dc.identifier.govdoc | 00153 | en |
dc.identifier.issn | 0142-6338 | en |
dc.identifier.uri | http://hdl.handle.net/11054/169 | en |
dc.description.abstract | The World Health Organization has produced guidelines for the management of common illnesses in hospitals with limited resources. This series reviews the scientific evidence behind WHO’s recommendations. The WHO guidelines and more reviews are available at: http://www.ichrc.org. The WHO Pocketbook of Hospital Care for Children [1] recommends treating children with cryptococcal meningitis with intravenous amphotericin B (0.5–1.5 mg kg−1 day−1) for 14 days followed by oral fluconazole (3–6 mg kg−1 day−1) for 8 weeks. Following the management of an acute episode, current recommendations advise ongoing prophylaxis with fluconazole. This review addresses the question: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV? | en |
dc.description.provenance | Approved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2013-01-14T00:09:10Z (GMT) No. of bitstreams: 0 | en |
dc.description.provenance | Submitted by Gemma Siemensma (gemmas@bhs.org.au) on 2013-01-14T00:09:00ZNo. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2013-01-14T00:09:10Z (GMT). No. of bitstreams: 0 Previous issue date: 2010 | en |
dc.publisher | Oxford University Press | en |
dc.relation.uri | http://tropej.oxfordjournals.org/content/56/1/4.extract | en |
dc.title | Evidence behind the WHO guidelines: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV? | en |
dc.type | Journal Article | en |
dc.type.specified | Article | en |
dc.bibliographicCitation.title | Journal of Tropical Pediatrics | en |
dc.bibliographicCitation.volume | 56 | en |
dc.bibliographicCitation.issue | 1 | en |
dc.bibliographicCitation.stpage | 4 | en |
dc.bibliographicCitation.endpage | 12 | en |
dc.publisher.place | Oxford | en |
dc.subject.healththesaurus | INFANTS | en |
dc.subject.healththesaurus | CLINICAL GUIDELINES | en |
dc.subject.healththesaurus | ANTIFUNGAL AGENTS | en |
dc.subject.healththesaurus | HIV | en |
dc.subject.healththesaurus | MENINGITIS | en |
dc.subject.healththesaurus | CRYPTOCCAL MENINGITIS | en |
dc.date.issuedbrowse | 2010-01-01 | en |
Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.